Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Mesa Laboratories (MLAB) EBT Margin (2016 - 2025)

Historic EBT Margin for Mesa Laboratories (MLAB) over the last 16 years, with Q4 2025 value amounting to 7.06%.

  • Mesa Laboratories' EBT Margin rose 105900.0% to 7.06% in Q4 2025 from the same period last year, while for Dec 2025 it was 5.68%, marking a year-over-year increase of 1191800.0%. This contributed to the annual value of 2.47% for FY2025, which is 1299800.0% up from last year.
  • Latest data reveals that Mesa Laboratories reported EBT Margin of 7.06% as of Q4 2025, which was up 105900.0% from 3.29% recorded in Q3 2025.
  • Mesa Laboratories' EBT Margin's 5-year high stood at 12.89% during Q1 2021, with a 5-year trough of 467.42% in Q1 2024.
  • In the last 5 years, Mesa Laboratories' EBT Margin had a median value of 3.41% in 2022 and averaged 20.61%.
  • Per our database at Business Quant, Mesa Laboratories' EBT Margin crashed by -4669300bps in 2024 and then skyrocketed by 4681700bps in 2025.
  • Mesa Laboratories' EBT Margin (Quarter) stood at 4.28% in 2021, then surged by 182bps to 3.53% in 2022, then rose by 3bps to 3.64% in 2023, then plummeted by -197bps to 3.53% in 2024, then soared by 300bps to 7.06% in 2025.
  • Its EBT Margin stands at 7.06% for Q4 2025, versus 3.29% for Q3 2025 and 11.78% for Q2 2025.